Skip to main content
SpringerLink
Log in

Compactin—a review

  • Mini-Review
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Compactin, a hypocholesterolemic molecule, is a competitive inhibitor of 3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase, which is a regulatory enzyme for cholesterol biosynthesis. The structural similarity and high affinity of the acid form of compactin and HMG, the natural substrate of enzyme, results in specific and effective inhibition of this enzyme. Inhibition results in reduced levels of mevalonic acid in the body, leading to pleiotropic effects. Various fungi have been used for the commercial production of compactin. Using different strategies for improving production levels, yields have been increased to around 900 times of the amount originally produced. Recently, the gene sequence responsible for compactin production has been cloned and sequenced. This review deals with the chemistry, mode of action, pharmacology, biosynthesis, and production of compactin. A comparative study of various reports dealing with the production of compactin is also included.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Abe Y, Suzuki T, Ono C, Iwamoto K, Hosobuchi M, Yoshikawa H (2002a) Molecular cloning and characterization of an ML-236B (compactin) biosynthetic gene cluster in Penicillium citrinum. Mol Genet Genomics 267:636–646

    CAS  PubMed  Google Scholar 

  • Abe Y, Suzuki T, Mizuno T, Ono C, Iwamoto K, Hosobuchi M, Yoshikawa H (2002b) Effects of increased dosage of the ML-236B (compactin) biosynthetic gene cluster on ML-236B production in Penicillium citrinum. Mol Genet Genomics 268:130–137

    CAS  PubMed  Google Scholar 

  • Albers-Schonberg, Joshou H, Lopez MB (1981) Hypocholesteremic fermentation products and products of preparation. US Patent 4 294 846

  • Alberts AW (1998) Discovery, biochemistry and biology of lovastatin. Am J Cardiol 62:10J–15J

    Google Scholar 

  • Amin-Hanjani S, Stagliano NE, Yamada M, Huang PL, Liao JK, Mosokowitz MA (2001) Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 32:980–986

    PubMed  Google Scholar 

  • Askenazi M, Driggers EM, Holtzman DA, Norman TC, Iverson S, Zimmer DP, Boers ME, Blomquist PR, Martinez EJ, Monreal AW, Feibelman TP, Mayorga ME, Maxon ME, Sykes K, Tobin JV, Cordero E, Salama SR, Trueheart J, Royer JC, Madden KT (2003) Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains. Nat Biotechnol 21:150–156

    Article  CAS  PubMed  Google Scholar 

  • Bazaraa WA, Hamdy MK, Toledo R (1998) Bioreactor for continuous synthesis of compactin by Penicillium cyclopium. J Ind Microbiol Biotechnol 2:192–202

    Article  Google Scholar 

  • Beg ZH, Stonik JA (1982) Reversible inactivation of 3-hydroxy-3-methylglutaryl coenzyme A reductase: reductase kinase and meavlonate kinase are separate enzymes. Biochem Biophys Res Commun 108:559–566

    PubMed  Google Scholar 

  • Bowmen L, Geiger E (1984) Optimization of fermentation conditions for alcohol production. Biotechnol Bioeng 26:1492–1497

    Google Scholar 

  • Brown AG, Smale TC, King J, Hasenkamp R, Thompson RH (1976) Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum. J Chem Soc Perkin 1:1165–1170

    Google Scholar 

  • Brown MS, Faust JR, Goldstein JL (1978) Induction of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in human fibroblasts incubated with compactin (ML-236B), A competitive inhibitor of the reductase. J Biol Chem 253:1121–1128

    CAS  PubMed  Google Scholar 

  • Byrne GS, Ward OP (1989) Effect of nutrition on pellet formation by Rhizopus arrhizus. Biotechnol Bioeng 33:912–914

    CAS  Google Scholar 

  • Chakravarti R, Sahai V (2002a) A chemically-defined medium for production of compactin by Penicillium citrinum. Biotechnol Lett 24:527–530

    Article  Google Scholar 

  • Chakravarti R, Sahai V (2002b) Optimisation of compactin production in chemically defined production medium by Penicillium citrinum using statistical methods. Process Biochem 38:481–486

    Article  Google Scholar 

  • Chung KJ, Lee JK, Park JW, Seo DJ, Lee SC (2001) Method for producing pravastatin precursor, ML-236B. US Patent 6 204 032

  • Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, Bernini F (1999) New insights into the pharmacodynamics and pharmokinetics properties of statins. Pharmacol Theraput 84:413–428

    Article  Google Scholar 

  • Davidson MH, Jacobson TA (2001) How statins work: the development of cardiovascular diseases and its treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. www.medscape.com/viewprogram/608

    Google Scholar 

  • Davignon J, Mabile L (2001) Mechanisms of action of statins and their pleiotropic effects. Ann Endocinol 62:101–112

    CAS  Google Scholar 

  • Davis BL, Cino PM, Szarka L (2000) Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof. US Patent 6 043,064

  • Demain AL, Kennel YM, Aharonowitz Y (1979) Carbon catabolic regulation of secondary metabolism. Microbial technology: current status, future prospects. Symp Soc Gen Microbiol 29:168–185

    Google Scholar 

  • Demain AL, Peng Y, Yashphe J, Davis J (1999) Conversion of compactin to pravastatin by Actinomadura. US Patent 5 942 423

  • Demain AL, Peng Y, Yashphe J, Davis J (2001) Conversion of compactin to pravastatin by Actinomadura. US Patent 6 274 360

  • Dey G, Mitra A, Banerjee R, Maiti BR (2001) Enhanced production of amylase by optimization of nutritional constituents using response surface methodology. Biochem Eng J 7:227–231

    Article  Google Scholar 

  • Endo A (1985) Compactin (ML-236 B) and related compounds as potential cholesterol lowering agents that HMG-CoA reductase. J Med Chem 28:400–405

    Google Scholar 

  • Endo A, Yamashita H (1985) Microbial phosphorylation of compactin (ML-236B) and related compounds. J Antibiot 38:328–332

    PubMed  Google Scholar 

  • Endo A, Kuroda M, Tsujita Y (1976a) ML-236A, ML-236B and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. J Antibiot 29:1346–1348

    CAS  Google Scholar 

  • Endo A, Kuroda M, Tanzawa K (1976b) Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B, fungal metabolites, having hypocholesterolemic activity. FEBS Lett 72:323–326

    CAS  Google Scholar 

  • Endo A, Kuroda M, Terahara A, Yoshio T, Chhiro T (1977) Physiologically active substances and fermentative process for producing the same. US Patent 4049495

  • Endo A, Hasumi K, Negishi S (1985a) Monacolins J and L, new inhibitors of cholesterol biosynthesis produced by Monascus rubber. J Antibiot 38:420–423

    PubMed  Google Scholar 

  • Endo A, Negishi Y, Iwashita T, Mizukawa K, Hirama M (1985b) Biosynthesis of ML-236B (compactin) and monacolin K. J Antibiot 38:444–448

    CAS  PubMed  Google Scholar 

  • Endo A, Hasumi K, Yamada A, Shimoda R, Takeshima H (1986) The synthesis of compactin (ML-236B) and monacolin K in fungi. J Antibiot 39:1609–1610

    PubMed  Google Scholar 

  • Gallo M, Katz E (1972) Regulation of secondary metabolite biosynthesis: catabolite repression of phenoxazine synthase and actinomycin formation by glucose. J Bacteriol 109:659–667

    PubMed  Google Scholar 

  • Galloway P, Greer IA, Sattar N (2002) Statins as novel therapies for osteoporosis. Eur J Obstet Gynecol Reprod Biol 101:4–5

    Article  PubMed  Google Scholar 

  • George R, Menon AS, Ramasarma T (1980) Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by adenosine derivatives and fatty acylcoenzyme A. Ind J Biochem Biophys 17:1–7

    CAS  Google Scholar 

  • Gerson DF, Xiao X (1995) Process for the production of lovastatin using Coniothyrium fuckelii. US Patent 5 409 820

    Google Scholar 

  • Hamelin BA, Turgeon J (1998) Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharamcol Sci 19:26–37

    Article  Google Scholar 

  • Hosobuchi M, Shiori T, Ohyama J, Arai M, Iwado S, Yoshikawa H (1993a) Production of ML-236B, and inhibitor of 3-hydroxy-3-methylglutaryl CoA reductase, by Penicillium citrinum: improvement of strain and culture conditions. Biosci Biotechnol Biochem 57:1414–1419

    CAS  Google Scholar 

  • Hosobuchi M, Ogawa K, Yoshikawa H (1993b) Morphology study in production of ML-236B, a precursor of pravastatin sodium by Penicillium citrinum. J Ferment Bioeng 76:470–475

    CAS  Google Scholar 

  • Hosobuchi M, Fukui F, Matsukawa H, Suzuki T, Yoshikawa H (1993c) Morphology control of preculture during production of pravastatin sodium by Penicillium citrinum. J Ferment Bioeng 76:476–481

    CAS  Google Scholar 

  • Hosobuchi M, Fukui F, Suzuki T, Yoshikawa H (1993d) Fuzzy control in microbial production of ML-236B, a precursor of pravastatin sodium. J Ferment Bioeng 76:482–486

    CAS  Google Scholar 

  • Hutchinson CR, Kennedy J, Park C, Kendrew S, Auclair K, Vederas J (2000) Aspects of the biosynthesis of non-aromatic fungal polyketide by iterative polyketide synthases. Antonie van Leeuwenhoek 78:287–295

    CAS  PubMed  Google Scholar 

  • Kalil SJ, Maugeri F, Rodrigues MI (2000) Response surface analysis and simulation as a tool for bioprocess design and optimization. Process Biochem 35:539–550

    CAS  Google Scholar 

  • Koizumi J, Mabuchi H, Takeda R (1982) A possible translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase induction by ML-236B (compactin) in isolated rat hepatocytes. Biochem Biophys Res Commun 108:240–246

    PubMed  Google Scholar 

  • Komagata D Yamashita H, Endo A (1986) Microbial conversion of compactin (ML-236B) to ML-236A. J Antibiot 39:1574–1577

    PubMed  Google Scholar 

  • Konya A, Jekkel A, Suto J, Salat J (1998) Optimization of compactin fermentation. J Ind Microbiol Biotechnol 20:150–152

    Google Scholar 

  • Kranjc S, Ivnac I, Schauer M (2002) Biotechnological process for preparing hydroxylated ML-236B derivatives, known as M-4 and M-4′, and analogues thereof. US Patent 6 365 382

  • Kumar MS, Jana SK, Senthil V, Shasshanka S, Kumar V, Sadhukhan AK (2000) Repeated fed-batch process for improving Lovastatin production. Process Biochem 36:363–368

    Article  Google Scholar 

  • Manzoni M, Bergomi S, Rollni M, Cavazzoni V (1999) Production of statins by filamentous fungi. Biotechnol Lett 21:253–257

    CAS  Google Scholar 

  • Martin JF, Revilla G, Zanca DM, Lopez-Nieto MJ (1982) Carbon catabolite regulation of penicillin and cephalosporin biosynthesis. In: Umezawa H et al (eds) Proceedings of symposium Trends in Antibiotic Research. Japan Antibiotic Research Association, Tokyo, pp 258–268

  • Metz B, Kossen NWF, Van Suizdum JC (1979) The rheology of mould suspensions. Adv Biochem Eng 11:103–156

    Google Scholar 

  • Miller TL, Wolin MJ (2001) Inhibition of growth of methane-producing bacteria of the ruminant forestomach by hydroxymethylglutaryl-ScoA reductase inhibitors. J Dairy Sci 84:1445–1448

    PubMed  Google Scholar 

  • Mok T, Koehler AP, Yu MY, Ellis DH, Johnson PJ, Wickhan NW (1997) Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia. J Clin Microbiol 35:2654–2656

    PubMed  Google Scholar 

  • Morikawa S, Umetani M, Nakagawa S, Yamazaki H, Suganami H, Inoue K, Kitahara M, Hamakubo T, Kodama T, Saito Y (2000) Relative induction of mRNA for HMG-CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells. J Atheroscler Thromb 7:138–144

    PubMed  Google Scholar 

  • Nakanishi M, Goldstein JL, Brown MS (1988) Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. J Biol Chem 263:8929–8937

    PubMed  Google Scholar 

  • Narang S, Sahai V, Bisaria VS (2001) Optimization of xylanase production by Melanocarpus albomyces IIS68 in solid state fermentation using the response surface methodology. J Biosci Bioeng 9:425–427

    Article  Google Scholar 

  • Papagianni M, Mattey M, Kristiansen B (1994) Morphology and citric acid production of Aspergillus niger PM1. Biotechnol Lett 9:929–934

    Google Scholar 

  • Paul GC, Priede MA, Thomas CR (1999) Relationship between morphology and citric acid production in submerged Aspergillus niger fermentation. Biochem Eng J 3:121–129

    Article  Google Scholar 

  • Peng Y, Demain AL (1999) A new hydroxylase system in Actinomadura sp. cells converting compactin to pravastatin. J Ind Microbiol Biotechnol 20:373–375

    Google Scholar 

  • Peng Y, Yashbe J, Demain AL (1997) Biotransformation of compactin to pravastatin by Actinomadura sp. 2966. J Antibiot 52:1032–1035

    Google Scholar 

  • Plackett RL, Burman JP (1946) The design of optimum multifactorial experiments. Biometrika 33:305–325

    Google Scholar 

  • Prapulla SG, Jacob Z, Chand N, Rajalakshmi D, Karanth NG (1992) Maximization of lipid production by Rhodoterula gracilis CFR-1 using the response surface methodology. Biotechnol Bioeng 40:965–970

    CAS  Google Scholar 

  • Primrose S, King D, Yaworski ED, Radhakrishnan J, He D, Xiao X (1997) Fermentative process for preparation of compactin. US Patent 561173

  • Ramirez C (1982) Manual and atlas of the Penicillia. Elsevier, Amsterdam, pp 349–351

  • Reynolds KA, Demain AL (1997) Rapamycin, FK506 and ascomycin related compounds. In: Strohl WR (ed) Biotechnology of Antibiotics, 2nd edn. Dekker, New York, p 497

  • Roseiro JC, Esgalhado ME, Amaral Collaco MT, Emery AN (1992) Medium development for xanthan production. Process Biochem 27:167–175

    Article  Google Scholar 

  • Serizawa N, Nakagawa K, Hamano K, Tsujita Y, Terahara A, Kuwano H (1983a) Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530 B). J Antibiot 36:604–607

    PubMed  Google Scholar 

  • Serizawa N, Nakagawa K, Tsujita Y, Terahara A, Kuwano H (1983b) 3-Hydroxy-ML-236B (3-hydroxy compactin), microbial transformation product of ML-236B (compactin). J Antibiot 36:608–610

    PubMed  Google Scholar 

  • Serizawa N, Serizawa S, Nakagawa K, Furuya K, Okazaki T, Terahara A (1983c) Microbial hydroxylation of ML-236B (compactin), studies on microorganisms capable of 3α-hydroxylation of ML-236B. J Antibiot 36:887–891

    CAS  PubMed  Google Scholar 

  • Serizawa N, Nakagawa K, Tsujita Y, Terahara A, Kuwano H (1983d) 6-hydroxy-iso-ML-236B and ML-236A, microbial transformation products of ML-236B. J Antibiot 36:918–920

    PubMed  Google Scholar 

  • Sinensky M, Logel J (1983) Inhibition of degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevinolin. J Biol Chem 258:8547–8549

    PubMed  Google Scholar 

  • Smith JJ, Lilly MD, Fox RI (1990) The effect of agitation on the morphology and penicillin production of Penicillium chrysogenum. Biotechnol Bioeng 35:1011–1023

    CAS  Google Scholar 

  • Sugiyama M, Kodama T, Koniishi K, Abe K, Asami S, Oikawa S (2000) Compactin and Simvastatin, but not pravastatin, induces bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 271:688–692

    Article  CAS  PubMed  Google Scholar 

  • Sutherland A, Auclair K, Vederas (2001) Recent advances in the biosynthetic studies of lovastatin. Curr Opin Drug Discovery Dev 4:229–326

    CAS  Google Scholar 

  • Tanzawa K, Endo A (1979) Kinetic analysis of reaction catalyzed by rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase using two specific inhibitors. Eur J Biochem 98:195–210

    PubMed  Google Scholar 

  • Tobert JA (1987) New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl coenzyme A reductase. Circulation 76:534–538

    CAS  PubMed  Google Scholar 

  • Tony Lam YK, Gullo VP, Goeglman RT, Jorn D, Huang L, Deriso C, Monaghan RL, Putter I (1981) Dihydrocompactin, a new potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase from Penicillium citrinum. J Antibiot 34:614–616

    CAS  Google Scholar 

  • Vinci VA, Conder MJ, McAda PC, Phyllis C, Reeves CD, Rambosek J, Davis CR, Hendrickson LE (2001) DNA encoding triol polyketide synthase. US Patent 6 174 706

  • Wächtershäuser A, Akoglu B, Stein J (2001) HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2. Carcinogenesis 22:1061–1067

    Article  PubMed  Google Scholar 

  • Wang YP, Chen YC, Chang W, Lin CL (2001) Mutant strain of Penicillium citrinum and use thereof for preparation of compactin. US Patent 6 323 021

  • Wasser SP, Reshetnikov SV (2002) Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms. US Patent 6 372 462

    Google Scholar 

  • Yamashita H, Tsubokawa S, Endo A (1985) Microbial hydroxylation of compactin (ML-236B) and monacolin K. J Antibiot 38:605–609

    PubMed  Google Scholar 

  • Ykema A, Lindsay JM (2000) Nitrogen feed in statin fermentation. US Patent 6 165 757

    Google Scholar 

  • Yuki A, Hosobuchi M, Yoshokawa H (2001) Penicillium citrinum genes associated with biosynthesis of ML-236B, precursor of 3-hydroxy-3-methylglutaryl CoA reductase inhibitor. World Patent 0112814

Download references

Author information

Author notes

  1. R. Chakravarti

    Present address: Department of Cell Biology, LRI, Cleveland Clinic Foundation, Cleveland, OH 44120, USA

Authors and Affiliations

  1. Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology-Delhi, Hauz Khas, 110016, New Delhi, India

    R. Chakravarti & V. Sahai

Authors
  1. R. Chakravarti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Sahai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Sahai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chakravarti, R., Sahai, V. Compactin—a review. Appl Microbiol Biotechnol 64, 618–624 (2004). https://doi.org/10.1007/s00253-003-1553-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-003-1553-7

Keywords

Search

Navigation